ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
The neurologist of 2050: Rethinking the role in movement disorders in a technologically transformed society.
Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionArtificial intelligence (AI), digital health technologies, and neuroengineering are rapidly transforming the diagnosis and management of movement disorders. By 2050, these innovations, together with profound demographic, cultural, and economic changes, are expected to reshape the role of neurologists far beyond current clinical practice.
methodsmovement disorder specialists may evolve from a primarily diagnostic clinician into an orchestrator of personalized neurocare, integrating multimodal digital biomarkers, AI-driven decision support systems, wearable technologies, closed-loop neuromodulation,and disease-modifying therapies. RESULTS AND DISCUSSION: We argue that future neurological care will increasingly rely on continuous home-based monitoring, predictive modeling, and individualized therapeutic strategies based on biological, clinical and 'social' information rather than purely clinical disease definitions. At the same time, population aging, healthcare sustainability, and disparities in access toadvanced technologies will require neurologists to assume broader responsibilities as multidisciplinary coordinators, integrating clinicalexpertise with data science, ethics, and health economics. Despite the growing role of AI, clinical reasoning, empathy, communication,and shared decision-making will remain irreplaceable components of neurological care. Rather than replacing neurologists, AI is likelyto increase the need for highly trained specialists capable of critically interpreting algorithmic outputs, recognizing their limitations, andcontextualizing recommendations within each patient's biological, psychological, and social framework. The neurologist of 2050 willtherefore become not only a clinician, but also a guarantor of trustworthy, equitable, and human centered precision neurology.
Indexed as
Identifiers
42567953What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.